At the end of the latest market close, NRx Pharmaceuticals Inc. (NRXP) was valued at $10.98. In that particular session, Stock kicked-off at the price of $11.50 while reaching the peak value of $13.39 and lowest value recorded on the day was $11.07. The stock current value is $12.64.Recently in News on September 8, 2021, NRx Pharmaceuticals to Participate in H.C. Wainwright 23rd Annual Global Investment Conference. NRx Pharmaceuticals (NRx) (Nasdaq: NRXP) today announced that NRx’s management team will present and host one-on-one investor meetings at the upcoming H.C. Wainwright Global Investment Conference September 13-15, 2021. You can read further details here
NRx Pharmaceuticals Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $64.20 on 02/02/21, with the lowest value was $8.39 for the same time period, recorded on 07/16/21.
NRx Pharmaceuticals Inc. (NRXP) full year performance was 14.39%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, NRx Pharmaceuticals Inc. shares are logging -83.58% during the 52-week period from high price, and 50.66% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $8.39 and $76.99.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2617724 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the NRx Pharmaceuticals Inc. (NRXP) recorded performance in the market was -48.20%, having the revenues showcasing -27.85% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 677.38M, as it employees total of 2 workers.
The Analysts eye on NRx Pharmaceuticals Inc. (NRXP)
During the last month, 0 analysts gave the NRx Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 18.52, with a change in the price was noted -20.32. In a similar fashion, NRx Pharmaceuticals Inc. posted a movement of -61.65% for the period of last 100 days, recording 3,182,584 in trading volumes.
Technical rundown of NRx Pharmaceuticals Inc. (NRXP)
Raw Stochastic average of NRx Pharmaceuticals Inc. in the period of last 50 days is set at 23.81%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 23.92%. In the last 20 days, the company’s Stochastic %K was 13.84% and its Stochastic %D was recorded 15.95%.
Considering, the past performance of NRx Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -48.20%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -59.90%, alongside a boost of 14.39% for the period of the last 12 months. The shares increased approximately by -2.47% in the 7-day charts and went up by -16.95% in the period of the last 30 days. Common stock shares were lifted by -27.85% during last recorded quarter.